CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
NECTAR explores a novel treatment for Alzheimer's Disease using neutron capture nuclear reactions to target harmful protein aggregates in the brain. The project aims to develop biocompatible probes and a detailed model to assess the safety and effectiveness of this innovative therapy.
NECTAR proposes an alternative and revolutionary strategy to address AD (Alzheimer’s Disease) treatment, suggesting and investigating a therapy based mainly on nuclear physics principles and phenomena, i.e. neutron capture nuclear reactions and structural damage of AD Aβ aggregates induced by ionizing radiations (IRs). AD is the most common cause of dementia.
There is no cure and no new FDA medication has been approved since 2002. NECTAR aims to develop, test and prove the feasibility, safety a…
UNIVERSITA DEGLI STUDI DI PAVIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Torino
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, SAN ZENO NAVIGLIO
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
